arrow
C

Carmel Pezaro

monash university
H指数:32
被引数:4,161

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

晚期前列腺癌-转移性和/或去势抵抗性前列腺癌患者的管理: 晚期前列腺癌共识会议 (APCCC) 2022的报告

2023-05-0166
OA
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

晚期前列腺癌患者的管理。第一部分: 中/高危和局部晚期疾病,生化复发和激素治疗的副作用: 晚期前列腺癌共识会议2022的报告

2023-03-0164
OA
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)

醋酸阿比特龙联合泼尼松龙治疗开始激素治疗的转移性患者: STAMPEDE随机试验 (NCT00268476) 的5年随访结果

2022-05-1656
OA
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition

CX-5461使DNA损伤修复熟练的去势抵抗性前列腺癌对PARP抑制敏感

2021-08-1916
OA
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology

前列腺癌患者来源的异种移植物的壁画收集可以通过尿肿瘤的临床前模型进行发现

2021-08-1948
OAAI
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial
2021-07-0146
OAAI
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium

同步与异时转移性疾病: 转移时间对患者预后的影响-国际转移性肾细胞癌数据库联盟的结果

2020-08-0131
OAAI
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis

晚期前列腺癌治疗后4周早期前列腺特异性抗原及阿比特龙和恩扎鲁他胺治疗: 一项国际合作分析

2020-04-0119
OAAI
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

阿比曲酮和恩扎鲁他胺耐药的前列腺癌的患者衍生模型显示出对核糖体定向治疗的敏感性

2018-11-0190
OAAI
High-risk pathologic and genomic features of BRCA2-mutant prostate cancer.
2018-08-140
PRE
Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer
2017-08-014
OAAI
Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category
2017-06-0112
PREAI